DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0152018 | Esophageal carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0751690 | Malignant Peripheral Nerve Sheath Tumor | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0700095 | Central neuroblastoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0019158 | Hepatitis | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0011849 | Diabetes Mellitus | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0025517 | Metabolic Diseases | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0400966 | Non-alcoholic Fatty Liver Disease | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0010068 | Coronary heart disease | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0546837 | Malignant neoplasm of esophagus | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C1332206 | Adult Lymphoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0024299 | Lymphoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C2239176 | Liver carcinoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0009402 | Colorectal Carcinoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0027651 | Neoplasms | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C1853926 | NONAKA MYOPATHY | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0036572 | Seizures | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C1096902 | Infantile Sialic Acid Storage Disease | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0751336 | Distal Muscular Dystrophies | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0026848 | Myopathy | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0027651 | Neoplasms | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0276289 | Zika Virus Infection | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0342853 | Sialuria | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C1096903 | Sialic Acid Storage Disease, Finnish Type (disorder) | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0015469 | Facial paralysis | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0346647 | Malignant neoplasm of pancreas | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024